Loading...

Hugo Villar

TitleTeacher
InstitutionUniversity of California San Diego
Address9500 Gilman Drive #0170-P
La Jolla CA 92093
Phone858-534-9354
vCardDownload vCard

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help.
    List All   |   Timeline
    1. Hansen MR, Villar H, Feyfant E. Development of an informatics platform for therapeutic protein and peptide analytics. J Chem Inf Model. 2013 Oct 28; 53(10):2774-9. PMID: 24099460.
      View in: PubMed
    2. Villar H, Hansen MR. Design of chemical libraries for screening. Expert Opin Drug Discov. 2009 Dec; 4(12):1215-20. PMID: 23480462.
      View in: PubMed
    3. Villar H, Hansen MR. Mining and visualizing the chemical content of large databases. Curr Opin Drug Discov Devel. 2009 May; 12(3):367-75. PMID: 19396738.
      View in: PubMed
    4. Villar H, Hansen MR. Computational techniques in fragment based drug discovery. Curr Top Med Chem. 2007; 7(15):1509-13. PMID: 17897037.
      View in: PubMed
    5. Villar H. Computational medicinal chemistry. Curr Top Med Chem. 2007; 7(15):1489-90. PMID: 17897034.
      View in: PubMed
    6. Kho R, Hodges JA, Hansen MR, Villar H. Ring systems in mutagenicity databases. J Med Chem. 2005 Oct 20; 48(21):6671-8. PMID: 16220983.
      View in: PubMed
    7. Hsu N, Cai D, Damodaran K, Gomez RF, Keck JG, Laborde E, Lum RT, Macke TJ, Martin G, Schow SR, Simon RJ, Villar H, Wick MM, Beroza P. Novel cyclooxygenase-1 inhibitors discovered using affinity fingerprints. J Med Chem. 2004 Sep 23; 47(20):4875-80. PMID: 15369391.
      View in: PubMed
    8. Villar H, Yan J, Hansen MR. Using NMR for ligand discovery and optimization. Curr Opin Chem Biol. 2004 Aug; 8(4):387-91. PMID: 15288248.
      View in: PubMed
    9. Sem DS, Bertolaet B, Baker B, Chang E, Costache AD, Coutts S, Dong Q, Hansen M, Hong V, Huang X, Jack RM, Kho R, Lang H, Ma CT, Meininger D, Pellecchia M, Pierre F, Villar H, Yu L. Systems-based design of bi-ligand inhibitors of oxidoreductases: filling the chemical proteomic toolbox. Chem Biol. 2004 Feb; 11(2):185-94. PMID: 15123280.
      View in: PubMed
    10. Kho R, Newman JV, Jack RM, Villar H, Hansen MR. Genome-wide profile of oxidoreductases in viruses, prokaryotes, and eukaryotes. J Proteome Res. 2003 Nov-Dec; 2(6):626-32. PMID: 14692456.
      View in: PubMed
    11. Kho R, Baker BL, Newman JV, Jack RM, Sem DS, Villar H, Hansen MR. A path from primary protein sequence to ligand recognition. Proteins. 2003 Mar 01; 50(4):589-99. PMID: 12577265.
      View in: PubMed
    12. Villar H. Chemical genomics - Active Communications International Conference. IDrugs. 2002 Dec; 5(12):1118-20. PMID: 14689952.
      View in: PubMed
    13. Beroza P, Villar H, Wick MM, Martin GR. Chemoproteomics as a basis for post-genomic drug discovery. Drug Discov Today. 2002 Aug 01; 7(15):807-14. PMID: 12546968.
      View in: PubMed
    14. Kho R, Hansen M, Baker B, Newman J, Sem DS, Jack R, Villar H. Elucidation of Protein Structural and Pharmacophore Features Based on Sequence Clustering by Common Neighbor Comparisons. ScientificWorldJournal. 2002; 2:17-18. PMID: 29973783.
      View in: PubMed
    Hugo's Networks
    Concepts
    Derived automatically from this person's publications.
    _
    Related Authors
    People who share related concepts with this person.
    _